A malaria vaccine, deployed in combination with current malaria-control tools, could play an important role in the future control and eventual elimination of malaria in Africa. This article, published in the New England Journal of Medicine, reports the initial results of an ongoing phase 3 trial of RTS,S/AS01 being conducted at 11 centers in seven African countries.